InDevR launches a new product that could shave weeks off the timeline to deliver flu vaccines in the event of a pandemic BOULDER (2/20/18) -- InDevR, a Boulder-based analytical technology and life ...

Recombinant baculoviruses (rBVs) have been extensively used to generate virus-like particles, and baculoviruses expressing antigenic proteins have become efficient tools for inducing protective ...

BOULDER, CO--(Marketwired - May 21, 2015) - InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced the launch of the VaxArray™ ...

Panel of antibodies developed at Mount Sinai will enable first multiplexed potency assay for tracking neuraminidase in flu vaccines InDevR, a Boulder-based progressive analytical technology and life ...

Unlike living organisms, to avoid extinction, viruses need to hijack living host machineries to generate new viruses. The devastating respiratory virus, influenza A virus, utilize its hemagglutinin ...

An experimental influenza vaccine carrying more than 80,000 variations of hemagglutinin antigens caused the immune system of mice and ferrets to respond more strongly to less variable portions of the ...

Classical antibody boosting effects during vaccination are accompanied by natural broadening mechanisms that help enable human antibodies to engage conserved sites of vulnerability on influenza virus.

Startled by the unexpected failure of a mid-stage trial of its vaccine adjuvant patch, Intercell AG is changing up the vaccine it used in the study along with the hemagglutinin inhibition assay used ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) Therapeutics™ to create a new generation of transformative ...

Discover comprehensive details about Influenza Vaccine, Recombinant Hemagglutinin, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or ...